Lantern Pharma Inc. (LTRN)

USD 3.53

(9.97%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 174.84 Thousand 154.68 Thousand 97.42 Thousand 3388.00 1627.00 -2544.00
Gross Profit -174.84 Thousand -154.68 Thousand -97.42 Thousand -3388.00 -1627.00 2544.00
Operating Expenses 17.87 Million 14.43 Million 12.59 Million 5.9 Million 2.42 Million 1.72 Million
Selling, General and Administrative Expenses 5.98 Million 5.82 Million 5.02 Million 3.66 Million 1.47 Million 1.15 Million
Research and Development Expenses 11.89 Million 8.6 Million 7.57 Million 2.24 Million 953.18 Thousand 572.09 Thousand
Other Expenses - -31.54 Thousand 160.55 Thousand - - -
Cost and Expenses 17.87 Million 14.43 Million 12.59 Million 5.9 Million 2.42 Million 1.72 Million
Operating Income -17.87 Million -14.43 Million -12.59 Million -5.9 Million -2.42 Million -1.72 Million
Interest Expense - 204.35 Thousand - - - -
Income Tax Expense - -172.8 Thousand -67.92 Thousand -202.9 Thousand -5.00 2544.00
Earnings before Tax -15.96 Million -14.25 Million -12.36 Million -5.9 Million -2.42 Million -1.72 Million
Net Income -15.96 Million -14.08 Million -12.29 Million -5.9 Million -2.42 Million -1.72 Million
Earnings Per Share Basic -1.47 -1.30 -1.13 -0.95 -0.39 -0.28
Earnings Per Share Diluted -1.47 -1.30 -1.13 -0.95 -0.39 -0.28
Weighted Average Shares Outstanding 10.84 Million 10.85 Million 10.9 Million 6.22 Million 6.26 Million 6.21 Million
Weighted Average Shares Outstanding (Diluted) 10.84 Million 10.85 Million 10.9 Million 6.22 Million 6.26 Million 6.21 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -15.78 Million -14.42 Million -12.26 Million -5.9 Million -2.42 Million -1.72 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts